Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PMV Pharmaceuticals, Inc. (PMVP : NSDQ)

• Company Description    PMV Pharmaceuticals Inc.is a precision oncology company. It engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. PMV Pharmaceuticals Inc.is headquartered in Cranbury, New Jersey. Number of Employees: 47

• Price / Volume Information    Yesterday's Closing Price: $1.25 Daily Weekly Monthly 20 Day Moving Average: 235,226 shares Shares Outstanding: 53.21 (millions) Market Capitalization: $66.51 (millions) Beta: 1.47 52 Week High: $1.84 52 Week Low: $0.81 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.34% -2.18% 12 Week -10.07% -11.52% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 400 Alexander Park Drive Suite 301 - Princeton,NJ 08540 USA ph: 609-642-6670 fax: - investors@pmvpharma.com http://www.pmvpharma.com

• General Corporate Information    Officers David H. Mack - President; Chief Executive Officer and Director Richard Heyman - Director and Chairman of the Board Michael Carulli - Chief Financial Officer Arnold Levine - Director Carol Gallagher - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 69353Y103 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/02/26 Share - Related Items Shares Outstanding: 53.21 Most Recent Split Date: (:1) Beta: 1.47 Market Capitalization: $66.51 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.29 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.39 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/02/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.55 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -8.11% vs. Previous Quarter: 2.44% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - -55.34 06/30/25 - -47.94 ROA 12/31/25 - - 09/30/25 - -51.01 06/30/25 - -43.82 Current Ratio 12/31/25 - - 09/30/25 - 10.77 06/30/25 - 12.52 Quick Ratio 12/31/25 - - 09/30/25 - 10.76 06/30/25 - 12.52 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - 2.28 06/30/25 - 2.71 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©